Endocrinology and Clinical Metabolic Research
A section of Metabolites (ISSN 2218-1989).
Section Information
Metabolites and metabolism have long been key parts of endocrinology and clinical metabolic research. This section of Metabolites now provides a venue to focus on these areas of investigation. In addition to those areas of traditional interest, such as precision medicine, biomarker discovery and inborn errors of metabolism, other clinically relevant areas will also be given full consideration.
These include, but are not limited to, original research and review articles on:
- metabolism in endocrine disorders
- cardio-metabolic risk
- fatty liver disease (NAFLD-NASH/MAFLD); cryptogenic and NAFLD-cirrhosis; NAFLD-HCC
- chronic kidney disease; fatty pancreas and gut microbiota
- adiposopathy and pathophysiology of adipose tissue
- immunity and metabolism
- metabolic derangements in infectious diseases
- sex medicine as applied to normal and deranged metabolism
- lifestyle and metabolism; chronometabolism; intermittent fasting
- biochemical and molecular characterization of pathophenotypes in internal medicine
In all these areas and many others, multidisciplinary and molecular approaches will represent added value. We hope our readers will appreciate the section “Endocrinology and Clinical Metabolic Research” and look forward to receiving high-quality scientific submissions from all over the world, while committing ourselves to the rapid and accurate processing of manuscripts.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Neuroendocrine Cancer Metabolism (Deadline: 15 June 2024)
- Exercise, Obesity and Metabolic Diseases (Deadline: 15 June 2024)
- Emerging Applications of Urinary Metabolomics in Cancer (Deadline: 25 June 2024)
- Exploring Potential Diagnostic and Prognostic Salivary Biomarkers in Cancer—2nd Edition (Deadline: 30 June 2024)
- Metabolomics: An Emerging Potential Approach to Study Critical Illnesses, 2nd Edition (Deadline: 30 June 2024)
- Metabolic Function and Mechanism of Enteroendocrine Cells and Gut Hormones (Deadline: 5 July 2024)
- Adipose Tissue, Reproduction and Metabolic Health in Women (Deadline: 10 July 2024)
- Glucose Metabolism in Pregnancy (Deadline: 20 July 2024)
- The Role of Hepatic Insulin Clearance in Obesity and Type 2 Diabetes (Deadline: 25 July 2024)
- Advances in Salivary Metabolomics for Oral and Systemic Diseases (Deadline: 31 July 2024)
- Targeting Microbiota and Metabolites for Prevention and Treatment of Human Diseases (Deadline: 31 July 2024)
- Lifestyle Interventions: A Challenging Therapeutic Strategy for Metabolic Syndrome 2nd Edition (Deadline: 15 August 2024)
- Honorary Special Issue Dedicated to Prof. Giovanni Targher–the Metabolic Fatty Liver Syndromes: MASLD/MAFLD/NAFLD (Deadline: 15 August 2024)
- Obesity and Metabolic Dysfunction: Disease Development and Breaking the Cycle (Deadline: 31 August 2024)
- Exercise Physiology and Cardiovascular Metabolism (Deadline: 31 August 2024)
- Metabolism and Immunomodulation in Liver Diseases (Deadline: 30 September 2024)
- Obesity and Metabolic Syndrome in Children: Insights, Interventions and Emerging Perspectives (Deadline: 30 September 2024)
- Novel Concept and Therapeutic Implications of Inborn Errors of Metabolism (Deadline: 30 September 2024)
- Metabolites as Biomarkers for Inherited Disorders (Deadline: 4 October 2024)
- Association between Cardiovascular Events and Metabolic Syndromes (Deadline: 15 October 2024)
- Effects of Chemical Exposure on Endocrine and Reproductive Functions (Deadline: 15 October 2024)
- Multimodal Approaches to Diagnosing Metabolic Bone Diseases (Deadline: 30 October 2024)
- New Advancements and Challenges in Clinical Metabolomics for Inborn Errors of Metabolism and Rare Diseases (Deadline: 31 October 2024)
- Mitochondrial Metabolism and Oxidative Stress in Hypertension, Diabetes and Related Complications (Deadline: 31 October 2024)
- Lipid Metabolism in Obesity and Diabetes, 2nd Edition (Deadline: 31 October 2024)
- Glucose Metabolism in Cardiovascular Diseases (Deadline: 31 October 2024)
- Research Progress of Plant Compounds for Diabetes and Its Complications, 2nd Edition (Deadline: 15 November 2024)
- The Multifaceted Roles of Biomarkers in Metabolic Disorders: From Diagnosis and Monitoring to Prediction, Management, and Treatment (Deadline: 26 November 2024)
- Cardiometabolic Disorders in Women (Deadline: 30 November 2024)
- Puberty and the Metabolic Syndrome (Deadline: 15 December 2024)
- Exploring Pathological Mechanisms in Obesity, Diabetes, and Metabolic Syndrome (Deadline: 20 December 2024)
- Interactions between Exercise Physiology and Metabolism (Deadline: 30 December 2024)
- Metabolic Programming of Hepatic Organ Function—2nd Edition (Deadline: 31 December 2024)
- Immunoregulatory Metabolites with Clinical Relevance (Deadline: 31 December 2024)
- Liver Injury and Regeneration—Metabolic Research (Deadline: 31 December 2024)
- Metabolomics in Chronic Disease (Deadline: 31 December 2024)
- Effects of the Glutamatergic System on Metabolic Alterations (Deadline: 31 December 2024)
- Energy Metabolism in Neurodegenerative Diseases (Deadline: 31 December 2024)
- Diabetes and Metabolic Diseases: From Prevention to Clinical Management (Deadline: 31 December 2024)
- Effects of Exercise on Cardiooncology and Cancer Metabolism (Deadline: 4 January 2025)
- Obesity and Metabolic Health (Deadline: 5 January 2025)
- Research on Biomarkers for Cardiometabolic Risk in Metabolic Syndrome (Deadline: 10 February 2025)
Topical Collection
Following topical collection within this section is currently open for submissions: